Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Tvardi Therapeutics (TVRD) Return on Capital Employed (2016 - 2025)

Tvardi Therapeutics' Return on Capital Employed history spans 12 years, with the latest figure at 101.12% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 6097.0% to 101.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 101.12%, a 6097.0% increase, with the full-year FY2025 number at 118.39%, down 7832.0% from a year prior.
  • Return on Capital Employed hit 101.12% in Q4 2025 for Tvardi Therapeutics, down from 92.25% in the prior quarter.
  • Over the last five years, Return on Capital Employed for TVRD hit a ceiling of 10.94% in Q3 2021 and a floor of 162.1% in Q4 2024.
  • Historically, Return on Capital Employed has averaged 76.89% across 5 years, with a median of 81.51% in 2025.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 8692bps in 2021 and later tumbled -7770bps in 2023.
  • Tracing TVRD's Return on Capital Employed over 5 years: stood at 40.78% in 2021, then decreased by -23bps to 50.19% in 2022, then tumbled by -155bps to 127.89% in 2023, then fell by -27bps to 162.1% in 2024, then skyrocketed by 38bps to 101.12% in 2025.
  • Business Quant data shows Return on Capital Employed for TVRD at 101.12% in Q4 2025, 92.25% in Q3 2025, and 90.42% in Q2 2025.